TUESDAY, Sept. 22, 2020 (HealthDay News) -- Perrigo inhalers have been recalled because they could clog and not provide patients with any or enough medication, the U.S. Food and Drug Administration says.
The retail recall is for all unexpired albuterol sulfate inhalation aerosol made by Catalent Pharma Solutions for Perrigo Pharmaceutical Company. The inhalers are used to treat asthma and other airway/lung conditions, such as chronic obstructive pulmonary disease. Patients should continue to use the Perrigo inhaler they have, as needed and as directed by a doctor, the FDA said.
Some of the recalled inhalers stop working after several uses. If their rescue albuterol inhaler malfunctions and does not relieve symptoms in an emergency situation, patients should immediately seek emergency care if needed, the FDA advised.
The agency recommends that patients have extra inhalers or an alternative treatment available in case of inhaler malfunction.
More Information
